Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3587 USD | +10.85% | +6.76% | -41.20% |
Mar. 21 | Dermata Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Jan. 05 | Wall Street Set to Open Lower as Monthly Jobs Data Much Stronger Than Expected | MT |
Evolution of the average Target Price on Dermata Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Dermata Therapeutics, Inc.
Maxim | |
Brookline Capital Management |
EPS Revisions
- Stock Market
- Equities
- DRMA Stock
- Consensus Dermata Therapeutics, Inc.